Company / Financials
Electromedical Technologies, Inc Financials
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.3M
FY2023 · +17.3% YoY
Net Income
-$2.6M
FY2023 · +23.9% YoY
Profit Margin
-195.8%
FY2023 · net income / revenue
ROE
-
FY2023 · return on equity
Total Assets
$748.4K
FY2023
Total Debt
$150.0K
-0.05x debt/equity
Equity
-$2.9M
FY2023
ROA
-352.9%
FY2023 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.3M+17.3% YoYNet Income HistoryProfit after all expenses and taxes-$2.6M+23.9% YoYGross Profit HistoryRevenue minus cost of goods sold$1.0M+17.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$303.3K+16.1% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$2.1M-28.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.1M+24.8% YoYR&D Expense HistoryResearch and development spending$231.4K+150.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$893.2K+12.9% YoYEPS (Basic) HistoryBasic earnings per share-$0.03+87.5% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.03+87.5% YoY